FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

INMUNE BIO INC.: cashflow_operating

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/57f4e511-41ae-4a20-89b3-4a1b6d56bc6d

Reported value

$-8.865M{"amount": -8865000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"}
Entity
INMUNE BIO INC.
Metric
cashflow_operating
Period
2022-01-01 – 2022-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-22-024226 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:31:21.098001+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001711754/cashflow-operating/2022-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.